Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database

Hussam Alhasson,1 Kadhim Al-banaa,2 Mohammad Abu-Tineh,3 Bassam Alhasson,4 Yu Zhao,1 Mohamed A Yassin3 1Department of Medicine, Rochester Regional Health, Rochester, NY, USA; 2Department of Hematology, University of California-San Diego, San Diego, CA, USA; 3National Center for Cancer Care and Resea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alhasson H, Al-banaa K, Abu-Tineh M, Alhasson B, Zhao Y, Yassin MA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
vte
Acceso en línea:https://doaj.org/article/8a1cf65f73b64a2bb166085a5252ca74
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8a1cf65f73b64a2bb166085a5252ca74
record_format dspace
spelling oai:doaj.org-article:8a1cf65f73b64a2bb166085a5252ca742021-11-09T18:40:34ZVenous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database1178-7074https://doaj.org/article/8a1cf65f73b64a2bb166085a5252ca742021-11-01T00:00:00Zhttps://www.dovepress.com/venous-thromboembolism-in-hospitalized-melanoma-patients-analysis-from-peer-reviewed-fulltext-article-IJGMhttps://doaj.org/toc/1178-7074Hussam Alhasson,1 Kadhim Al-banaa,2 Mohammad Abu-Tineh,3 Bassam Alhasson,4 Yu Zhao,1 Mohamed A Yassin3 1Department of Medicine, Rochester Regional Health, Rochester, NY, USA; 2Department of Hematology, University of California-San Diego, San Diego, CA, USA; 3National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; 4Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, USACorrespondence: Mohammad Abu-TinehHamad Medical Corporation, National Center for Cancer Care and Research, HMC, Alrayan Street, Doha, QatarEmail mabutineh@hamad.qaIntroduction: The association between cancer and hyper-coagulability is well known. However, the association between melanoma and venous thromboembolism (VTE) has not been identified.Methods: We studied the national inpatient sample (NIS) which compromise 20% of US hospitalization to better characterize melanoma and VTE. We analyzed the data between 2010 and 2014 using ICD-9 codes.Results: Melanoma patients were grouped into presence/absence of VTE. Multiple logistic regression was used to obtain the odds ratio (OR) to compare the mortality of the inpatient, total charges, length of stay (LOS), and disability at discharge. A total of 61,812 melanoma patients were identified, of which 5.2% were hospitalized for VTE. The presence of VTE was associated with a remarkable higher rate of discharge with a moderate to severe disability (57.5% vs 41.4%, P< 0.001), in-hospital stroke (7.6% vs 4.9%, P< 0.001), and in-hospital mortality (8.8% vs 5.1%, P< 0.001). Costs of hospitalization (64,720$ vs 46,606, P< 0.001) and LOS (5 vs 3 days, P< 0.001) were significantly higher as well in the VTE group. After adjusting for common confounder, VTE was found to be an independent predictor of mortality (OR = 1.596, 95% CI [1.399– 1.821], P< 0.001).Conclusion: In summary, melanoma patients with VTE had higher inpatient mortality, LOS, higher hospital cost, and a higher degree of disability upon discharge.Keywords: melanoma, venous thromboembolism, VTE, coagulationAlhasson HAl-banaa KAbu-Tineh MAlhasson BZhao YYassin MADove Medical Pressarticlemelanomavenous thromboembolismvtecoagulationMedicine (General)R5-920ENInternational Journal of General Medicine, Vol Volume 14, Pp 7855-7860 (2021)
institution DOAJ
collection DOAJ
language EN
topic melanoma
venous thromboembolism
vte
coagulation
Medicine (General)
R5-920
spellingShingle melanoma
venous thromboembolism
vte
coagulation
Medicine (General)
R5-920
Alhasson H
Al-banaa K
Abu-Tineh M
Alhasson B
Zhao Y
Yassin MA
Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
description Hussam Alhasson,1 Kadhim Al-banaa,2 Mohammad Abu-Tineh,3 Bassam Alhasson,4 Yu Zhao,1 Mohamed A Yassin3 1Department of Medicine, Rochester Regional Health, Rochester, NY, USA; 2Department of Hematology, University of California-San Diego, San Diego, CA, USA; 3National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; 4Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, USACorrespondence: Mohammad Abu-TinehHamad Medical Corporation, National Center for Cancer Care and Research, HMC, Alrayan Street, Doha, QatarEmail mabutineh@hamad.qaIntroduction: The association between cancer and hyper-coagulability is well known. However, the association between melanoma and venous thromboembolism (VTE) has not been identified.Methods: We studied the national inpatient sample (NIS) which compromise 20% of US hospitalization to better characterize melanoma and VTE. We analyzed the data between 2010 and 2014 using ICD-9 codes.Results: Melanoma patients were grouped into presence/absence of VTE. Multiple logistic regression was used to obtain the odds ratio (OR) to compare the mortality of the inpatient, total charges, length of stay (LOS), and disability at discharge. A total of 61,812 melanoma patients were identified, of which 5.2% were hospitalized for VTE. The presence of VTE was associated with a remarkable higher rate of discharge with a moderate to severe disability (57.5% vs 41.4%, P< 0.001), in-hospital stroke (7.6% vs 4.9%, P< 0.001), and in-hospital mortality (8.8% vs 5.1%, P< 0.001). Costs of hospitalization (64,720$ vs 46,606, P< 0.001) and LOS (5 vs 3 days, P< 0.001) were significantly higher as well in the VTE group. After adjusting for common confounder, VTE was found to be an independent predictor of mortality (OR = 1.596, 95% CI [1.399– 1.821], P< 0.001).Conclusion: In summary, melanoma patients with VTE had higher inpatient mortality, LOS, higher hospital cost, and a higher degree of disability upon discharge.Keywords: melanoma, venous thromboembolism, VTE, coagulation
format article
author Alhasson H
Al-banaa K
Abu-Tineh M
Alhasson B
Zhao Y
Yassin MA
author_facet Alhasson H
Al-banaa K
Abu-Tineh M
Alhasson B
Zhao Y
Yassin MA
author_sort Alhasson H
title Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
title_short Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
title_full Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
title_fullStr Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
title_full_unstemmed Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
title_sort venous thromboembolism in hospitalized melanoma patients: analysis from the national inpatient sample database
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/8a1cf65f73b64a2bb166085a5252ca74
work_keys_str_mv AT alhassonh venousthromboembolisminhospitalizedmelanomapatientsanalysisfromthenationalinpatientsampledatabase
AT albanaak venousthromboembolisminhospitalizedmelanomapatientsanalysisfromthenationalinpatientsampledatabase
AT abutinehm venousthromboembolisminhospitalizedmelanomapatientsanalysisfromthenationalinpatientsampledatabase
AT alhassonb venousthromboembolisminhospitalizedmelanomapatientsanalysisfromthenationalinpatientsampledatabase
AT zhaoy venousthromboembolisminhospitalizedmelanomapatientsanalysisfromthenationalinpatientsampledatabase
AT yassinma venousthromboembolisminhospitalizedmelanomapatientsanalysisfromthenationalinpatientsampledatabase
_version_ 1718440858540310528